Round Rock Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-425
Closed -$351K 223
2025
Q1
$351K Buy
425
+15
+4% +$12.5K 0.07% 157
2024
Q4
$317K Sell
410
-1
-0.2% -$828 0.07% 164
2024
Q3
$364K Sell
411
-11
-3% -$9.89K 0.09% 132
2024
Q2
$382K Buy
422
+53
+14% +$42.4K 0.09% 125
2024
Q1
$287K Buy
+369
New +$263K 0.07% 157

Other funds holding LLY

Round Rock Advisors's LLY Position: Q2 2025 in Review

Round Rock Advisors sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 425 shares — an estimated $351K sold.

Round Rock Advisors first reported a position in LLY in Q1 2024 and held it in 5 quarters. The position peaked at $382K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Round Rock Advisors reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Round Rock Advisors sold 425 Eli Lilly shares in Q2 2025, an estimated $351K.
  • Round Rock Advisors first reported a position in Eli Lilly in Q1 2024 and held it in 5 quarters.
  • Round Rock Advisors's Eli Lilly position peaked at $382K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Round Rock Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.